Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - candesartan cilexetil, quantity: 16 mg - tablet, uncoated - excipient ingredients: macrogol 8000; lactose monohydrate; carmellose calcium; magnesium stearate; hyprolose; maize starch; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - candesartan cilexetil, quantity: 8 mg - tablet, uncoated - excipient ingredients: hyprolose; lactose monohydrate; macrogol 8000; carmellose calcium; maize starch; magnesium stearate; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - candesartan cilexetil -

Spojené státy - angličtina - NLM (National Library of Medicine)

carilion materials management - candesartan cilexetil (unii: r85m2x0d68) (candesartan - unii:s8q36md2xx) - candesartan cilexetil 16 mg - candesartan cilexetil tablets are indicated for the treatment of hypertension in adults and children 1 to <17 years of age, to lower blood pressure. lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (j

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - candesartan cilexetil, quantity: 16 mg - tablet - excipient ingredients: magnesium stearate; maize starch; titanium dioxide; carrageenan; iron oxide red; povidone; croscarmellose sodium; lactose monohydrate - treatment of hypertension. . treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction less than or equal to 40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - candesartan cilexetil, quantity: 4 mg - tablet - excipient ingredients: lactose monohydrate; croscarmellose sodium; magnesium stearate; carrageenan; povidone; maize starch - treatment of hypertension. . treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction less than or equal to 40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - candesartan cilexetil, quantity: 32 mg - tablet - excipient ingredients: maize starch; magnesium stearate; titanium dioxide; povidone; lactose monohydrate; iron oxide red; carrageenan; croscarmellose sodium - treatment of hypertension. . treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction less than or equal to 40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

crescent pharma ltd - candesartan cilexetil - oral tablet - 8mg

Malta - angličtina - Medicines Authority

aspen healthcare malta limited 89, level 0 triq is-siggiewi siggiewi, sgw 2021, , malta - candesartan cilexetil, amlodipine - hard capsule - candesartan cilexetil 8 mg amlodipine 5 mg - agents acting on the renin-angiotensin system

Malta - angličtina - Medicines Authority

aspen healthcare malta limited 89, level 0 triq is-siggiewi siggiewi, sgw 2021, , malta - candesartan cilexetil, amlodipine - hard capsule - candesartan cilexetil 8 mg amlodipine 10 mg - agents acting on the renin-angiotensin system